HansBiomed Corporation (KOSDAQ:042520)
South Korea · Delayed Price · Currency is KRW 31,200
+100 (0.32%)
At close: Apr 29, 2026
HansBiomed Market Cap
HansBiomed has a market cap or net worth of 419.28 billion as of April 30, 2026. Its market cap has increased by 356.65% in one year.
Market Cap
419.28B
Enterprise Value
446.52B
Revenue
100.17B
Ranking
n/a
PE Ratio
n/a
Stock Price
31,200.00
Market Cap Chart
Since October 9, 2009, HansBiomed's market cap has increased from 49.00B to 419.28B, an increase of 755.59%. That is a compound annual growth rate of 13.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 419.28B | 10.99% |
| Dec 30, 2025 | 377.76B | 229.79% |
| Dec 30, 2024 | 114.55B | -39.92% |
| Dec 28, 2023 | 190.65B | 100.91% |
| Dec 29, 2022 | 94.89B | -16.49% |
| Dec 30, 2021 | 113.63B | -16.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventage Lab | 861.70B |
| IMBiologics | 792.00B |
| IntoCell | 603.13B |
| Kanaph Therapeutics | 492.95B |
| S.Biomedics | 424.81B |
| Kangstem Biotech | 386.56B |
| curacle co.,ltd. | 378.57B |
| Y-Biologics | 359.72B |